Loading…

Long-term measles antibody profiles following different vaccine schedules in China, a longitudinal study

Characterizing the long-term kinetics of maternally derived and vaccine-induced measles immunity is critical for informing measles immunization strategies moving forward. Based on two prospective cohorts of children in China, we estimate that maternally derived immunity against measles persists for...

Full description

Saved in:
Bibliographic Details
Published in:Nature communications 2023-03, Vol.14 (1), p.1746-1746, Article 1746
Main Authors: Wang, Qianli, Wang, Wei, Winter, Amy K., Zhan, Zhifei, Ajelli, Marco, Trentini, Filippo, Wang, Lili, Li, Fangcai, Yang, Juan, Xiang, Xingyu, Liao, Qiaohong, Zhou, Jiaxin, Guo, Jinxin, Yan, Xuemei, Liu, Nuolan, Metcalf, C. Jessica E., Grenfell, Bryan T., Yu, Hongjie
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c541t-7b76f13568a7dc1c9946830b263f50c6465a3f7cd72203df44b50ac86550d9df3
cites cdi_FETCH-LOGICAL-c541t-7b76f13568a7dc1c9946830b263f50c6465a3f7cd72203df44b50ac86550d9df3
container_end_page 1746
container_issue 1
container_start_page 1746
container_title Nature communications
container_volume 14
creator Wang, Qianli
Wang, Wei
Winter, Amy K.
Zhan, Zhifei
Ajelli, Marco
Trentini, Filippo
Wang, Lili
Li, Fangcai
Yang, Juan
Xiang, Xingyu
Liao, Qiaohong
Zhou, Jiaxin
Guo, Jinxin
Yan, Xuemei
Liu, Nuolan
Metcalf, C. Jessica E.
Grenfell, Bryan T.
Yu, Hongjie
description Characterizing the long-term kinetics of maternally derived and vaccine-induced measles immunity is critical for informing measles immunization strategies moving forward. Based on two prospective cohorts of children in China, we estimate that maternally derived immunity against measles persists for 2.4 months. Following two-dose series of measles-containing vaccine (MCV) at 8 and 18 months of age, the immune protection against measles is not lifelong, and antibody concentrations are extrapolated to fall below the protective threshold of 200 mIU/ml at 14.3 years. A catch-up MCV dose in addition to the routine doses between 8 months and 5 years reduce the cumulative incidence of seroreversion by 79.3–88.7% by the age of 6 years. Our findings also support a good immune response after the first MCV vaccination at 8 months. These findings, coupled with the effectiveness of a catch-up dose in addition to the routine doses, could be instrumental to relevant stakeholders when planning routine immunization schedules and supplemental immunization activities. The timing of measles vaccination in infants affects the risk of infection in young children and the duration of protection provided. Here, the authors investigate optimal vaccination timing by characterising antibody kinetics following different vaccine schedules in two cohorts of children in southern China.
doi_str_mv 10.1038/s41467-023-37407-x
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_0ecd787a51cf4e5babfabd8d7d2f27e3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_0ecd787a51cf4e5babfabd8d7d2f27e3</doaj_id><sourcerecordid>2792902315</sourcerecordid><originalsourceid>FETCH-LOGICAL-c541t-7b76f13568a7dc1c9946830b263f50c6465a3f7cd72203df44b50ac86550d9df3</originalsourceid><addsrcrecordid>eNp9kstu1DAUhiMEolXpC7BAkdiwIOC74xVCIy6VRmIDa8vxJeORYw92Ujpvj6cppWWBNz4-5z-fb3_TvITgHQS4f18IJIx3AOEOcwJ4d_OkOUeAwA5yhJ8-iM-ay1L2oA4sYE_I8-YMMyGA6Nl5s9umOHazzVM7WVWCLa2Ksx-SObaHnJw_ZVwKIf3ycWyNd85mG-f2Wmnto22L3lmznFQ-tpudj-ptq9pQqX5eTF2GttTg-KJ55lQo9vJuvmh-fP70ffO12377crX5uO00JXDu-MCZg5iyXnGjoRaCsB6DATHsKNCMMKqw49pwhAA2jpCBAqV7Rikwwjh80VytXJPUXh6yn1Q-yqS8vE2kPEqVZ6-DlcBWTM8VhdoRSwc1ODWY3nCDHOIWV9aHlXVYhskaXe-dVXgEfVyJfifHdC0hAJQgyCvhzR0hp5-LLbOcfNE2BBVtWopEXCBR_xDSKn39j3Sfllzfb1VBQRlDVYVWlc6plGzd_WkgkCdjyNUYskLlrTHkTW169fAe9y1_bFAFeBWUWoqjzX_3_g_2N1pmxfQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2792195662</pqid></control><display><type>article</type><title>Long-term measles antibody profiles following different vaccine schedules in China, a longitudinal study</title><source>Publicly Available Content Database</source><source>Nature</source><source>PubMed Central</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Wang, Qianli ; Wang, Wei ; Winter, Amy K. ; Zhan, Zhifei ; Ajelli, Marco ; Trentini, Filippo ; Wang, Lili ; Li, Fangcai ; Yang, Juan ; Xiang, Xingyu ; Liao, Qiaohong ; Zhou, Jiaxin ; Guo, Jinxin ; Yan, Xuemei ; Liu, Nuolan ; Metcalf, C. Jessica E. ; Grenfell, Bryan T. ; Yu, Hongjie</creator><creatorcontrib>Wang, Qianli ; Wang, Wei ; Winter, Amy K. ; Zhan, Zhifei ; Ajelli, Marco ; Trentini, Filippo ; Wang, Lili ; Li, Fangcai ; Yang, Juan ; Xiang, Xingyu ; Liao, Qiaohong ; Zhou, Jiaxin ; Guo, Jinxin ; Yan, Xuemei ; Liu, Nuolan ; Metcalf, C. Jessica E. ; Grenfell, Bryan T. ; Yu, Hongjie</creatorcontrib><description>Characterizing the long-term kinetics of maternally derived and vaccine-induced measles immunity is critical for informing measles immunization strategies moving forward. Based on two prospective cohorts of children in China, we estimate that maternally derived immunity against measles persists for 2.4 months. Following two-dose series of measles-containing vaccine (MCV) at 8 and 18 months of age, the immune protection against measles is not lifelong, and antibody concentrations are extrapolated to fall below the protective threshold of 200 mIU/ml at 14.3 years. A catch-up MCV dose in addition to the routine doses between 8 months and 5 years reduce the cumulative incidence of seroreversion by 79.3–88.7% by the age of 6 years. Our findings also support a good immune response after the first MCV vaccination at 8 months. These findings, coupled with the effectiveness of a catch-up dose in addition to the routine doses, could be instrumental to relevant stakeholders when planning routine immunization schedules and supplemental immunization activities. The timing of measles vaccination in infants affects the risk of infection in young children and the duration of protection provided. Here, the authors investigate optimal vaccination timing by characterising antibody kinetics following different vaccine schedules in two cohorts of children in southern China.</description><identifier>ISSN: 2041-1723</identifier><identifier>EISSN: 2041-1723</identifier><identifier>DOI: 10.1038/s41467-023-37407-x</identifier><identifier>PMID: 36990986</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>101/1 ; 631/326/590 ; 631/326/596/1631 ; 692/699/255/2514 ; 692/700/478/174 ; Adolescent ; Antibodies ; Antibodies, Viral ; Child ; Children ; China - epidemiology ; Health risks ; Humanities and Social Sciences ; Humans ; Immune response ; Immune system ; Immunity ; Immunization ; Infant ; Kinetics ; Longitudinal Studies ; Measles ; Measles - epidemiology ; Measles - prevention &amp; control ; Measles Vaccine ; multidisciplinary ; Prospective Studies ; Schedules ; Science ; Science (multidisciplinary) ; Vaccination ; Vaccines</subject><ispartof>Nature communications, 2023-03, Vol.14 (1), p.1746-1746, Article 1746</ispartof><rights>The Author(s) 2023. corrected publication 2023</rights><rights>2023. The Author(s).</rights><rights>The Author(s) 2023. corrected publication 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c541t-7b76f13568a7dc1c9946830b263f50c6465a3f7cd72203df44b50ac86550d9df3</citedby><cites>FETCH-LOGICAL-c541t-7b76f13568a7dc1c9946830b263f50c6465a3f7cd72203df44b50ac86550d9df3</cites><orcidid>0000-0003-1753-4749 ; 0000-0001-5028-2227 ; 0000-0002-6335-5648 ; 0000-0003-3166-7521</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2792195662/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2792195662?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,886,25755,27926,27927,37014,37015,44592,53793,53795,75128</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36990986$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Qianli</creatorcontrib><creatorcontrib>Wang, Wei</creatorcontrib><creatorcontrib>Winter, Amy K.</creatorcontrib><creatorcontrib>Zhan, Zhifei</creatorcontrib><creatorcontrib>Ajelli, Marco</creatorcontrib><creatorcontrib>Trentini, Filippo</creatorcontrib><creatorcontrib>Wang, Lili</creatorcontrib><creatorcontrib>Li, Fangcai</creatorcontrib><creatorcontrib>Yang, Juan</creatorcontrib><creatorcontrib>Xiang, Xingyu</creatorcontrib><creatorcontrib>Liao, Qiaohong</creatorcontrib><creatorcontrib>Zhou, Jiaxin</creatorcontrib><creatorcontrib>Guo, Jinxin</creatorcontrib><creatorcontrib>Yan, Xuemei</creatorcontrib><creatorcontrib>Liu, Nuolan</creatorcontrib><creatorcontrib>Metcalf, C. Jessica E.</creatorcontrib><creatorcontrib>Grenfell, Bryan T.</creatorcontrib><creatorcontrib>Yu, Hongjie</creatorcontrib><title>Long-term measles antibody profiles following different vaccine schedules in China, a longitudinal study</title><title>Nature communications</title><addtitle>Nat Commun</addtitle><addtitle>Nat Commun</addtitle><description>Characterizing the long-term kinetics of maternally derived and vaccine-induced measles immunity is critical for informing measles immunization strategies moving forward. Based on two prospective cohorts of children in China, we estimate that maternally derived immunity against measles persists for 2.4 months. Following two-dose series of measles-containing vaccine (MCV) at 8 and 18 months of age, the immune protection against measles is not lifelong, and antibody concentrations are extrapolated to fall below the protective threshold of 200 mIU/ml at 14.3 years. A catch-up MCV dose in addition to the routine doses between 8 months and 5 years reduce the cumulative incidence of seroreversion by 79.3–88.7% by the age of 6 years. Our findings also support a good immune response after the first MCV vaccination at 8 months. These findings, coupled with the effectiveness of a catch-up dose in addition to the routine doses, could be instrumental to relevant stakeholders when planning routine immunization schedules and supplemental immunization activities. The timing of measles vaccination in infants affects the risk of infection in young children and the duration of protection provided. Here, the authors investigate optimal vaccination timing by characterising antibody kinetics following different vaccine schedules in two cohorts of children in southern China.</description><subject>101/1</subject><subject>631/326/590</subject><subject>631/326/596/1631</subject><subject>692/699/255/2514</subject><subject>692/700/478/174</subject><subject>Adolescent</subject><subject>Antibodies</subject><subject>Antibodies, Viral</subject><subject>Child</subject><subject>Children</subject><subject>China - epidemiology</subject><subject>Health risks</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Immune response</subject><subject>Immune system</subject><subject>Immunity</subject><subject>Immunization</subject><subject>Infant</subject><subject>Kinetics</subject><subject>Longitudinal Studies</subject><subject>Measles</subject><subject>Measles - epidemiology</subject><subject>Measles - prevention &amp; control</subject><subject>Measles Vaccine</subject><subject>multidisciplinary</subject><subject>Prospective Studies</subject><subject>Schedules</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Vaccination</subject><subject>Vaccines</subject><issn>2041-1723</issn><issn>2041-1723</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kstu1DAUhiMEolXpC7BAkdiwIOC74xVCIy6VRmIDa8vxJeORYw92Ujpvj6cppWWBNz4-5z-fb3_TvITgHQS4f18IJIx3AOEOcwJ4d_OkOUeAwA5yhJ8-iM-ay1L2oA4sYE_I8-YMMyGA6Nl5s9umOHazzVM7WVWCLa2Ksx-SObaHnJw_ZVwKIf3ycWyNd85mG-f2Wmnto22L3lmznFQ-tpudj-ptq9pQqX5eTF2GttTg-KJ55lQo9vJuvmh-fP70ffO12377crX5uO00JXDu-MCZg5iyXnGjoRaCsB6DATHsKNCMMKqw49pwhAA2jpCBAqV7Rikwwjh80VytXJPUXh6yn1Q-yqS8vE2kPEqVZ6-DlcBWTM8VhdoRSwc1ODWY3nCDHOIWV9aHlXVYhskaXe-dVXgEfVyJfifHdC0hAJQgyCvhzR0hp5-LLbOcfNE2BBVtWopEXCBR_xDSKn39j3Sfllzfb1VBQRlDVYVWlc6plGzd_WkgkCdjyNUYskLlrTHkTW169fAe9y1_bFAFeBWUWoqjzX_3_g_2N1pmxfQ</recordid><startdate>20230329</startdate><enddate>20230329</enddate><creator>Wang, Qianli</creator><creator>Wang, Wei</creator><creator>Winter, Amy K.</creator><creator>Zhan, Zhifei</creator><creator>Ajelli, Marco</creator><creator>Trentini, Filippo</creator><creator>Wang, Lili</creator><creator>Li, Fangcai</creator><creator>Yang, Juan</creator><creator>Xiang, Xingyu</creator><creator>Liao, Qiaohong</creator><creator>Zhou, Jiaxin</creator><creator>Guo, Jinxin</creator><creator>Yan, Xuemei</creator><creator>Liu, Nuolan</creator><creator>Metcalf, C. Jessica E.</creator><creator>Grenfell, Bryan T.</creator><creator>Yu, Hongjie</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><general>Nature Portfolio</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7ST</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>RC3</scope><scope>SOI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-1753-4749</orcidid><orcidid>https://orcid.org/0000-0001-5028-2227</orcidid><orcidid>https://orcid.org/0000-0002-6335-5648</orcidid><orcidid>https://orcid.org/0000-0003-3166-7521</orcidid></search><sort><creationdate>20230329</creationdate><title>Long-term measles antibody profiles following different vaccine schedules in China, a longitudinal study</title><author>Wang, Qianli ; Wang, Wei ; Winter, Amy K. ; Zhan, Zhifei ; Ajelli, Marco ; Trentini, Filippo ; Wang, Lili ; Li, Fangcai ; Yang, Juan ; Xiang, Xingyu ; Liao, Qiaohong ; Zhou, Jiaxin ; Guo, Jinxin ; Yan, Xuemei ; Liu, Nuolan ; Metcalf, C. Jessica E. ; Grenfell, Bryan T. ; Yu, Hongjie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c541t-7b76f13568a7dc1c9946830b263f50c6465a3f7cd72203df44b50ac86550d9df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>101/1</topic><topic>631/326/590</topic><topic>631/326/596/1631</topic><topic>692/699/255/2514</topic><topic>692/700/478/174</topic><topic>Adolescent</topic><topic>Antibodies</topic><topic>Antibodies, Viral</topic><topic>Child</topic><topic>Children</topic><topic>China - epidemiology</topic><topic>Health risks</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Immune response</topic><topic>Immune system</topic><topic>Immunity</topic><topic>Immunization</topic><topic>Infant</topic><topic>Kinetics</topic><topic>Longitudinal Studies</topic><topic>Measles</topic><topic>Measles - epidemiology</topic><topic>Measles - prevention &amp; control</topic><topic>Measles Vaccine</topic><topic>multidisciplinary</topic><topic>Prospective Studies</topic><topic>Schedules</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Vaccination</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Qianli</creatorcontrib><creatorcontrib>Wang, Wei</creatorcontrib><creatorcontrib>Winter, Amy K.</creatorcontrib><creatorcontrib>Zhan, Zhifei</creatorcontrib><creatorcontrib>Ajelli, Marco</creatorcontrib><creatorcontrib>Trentini, Filippo</creatorcontrib><creatorcontrib>Wang, Lili</creatorcontrib><creatorcontrib>Li, Fangcai</creatorcontrib><creatorcontrib>Yang, Juan</creatorcontrib><creatorcontrib>Xiang, Xingyu</creatorcontrib><creatorcontrib>Liao, Qiaohong</creatorcontrib><creatorcontrib>Zhou, Jiaxin</creatorcontrib><creatorcontrib>Guo, Jinxin</creatorcontrib><creatorcontrib>Yan, Xuemei</creatorcontrib><creatorcontrib>Liu, Nuolan</creatorcontrib><creatorcontrib>Metcalf, C. Jessica E.</creatorcontrib><creatorcontrib>Grenfell, Bryan T.</creatorcontrib><creatorcontrib>Yu, Hongjie</creatorcontrib><collection>SpringerOpen</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Environment Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Database‎ (1962 - current)</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Biological Science Journals</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Genetics Abstracts</collection><collection>Environment Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Nature communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Qianli</au><au>Wang, Wei</au><au>Winter, Amy K.</au><au>Zhan, Zhifei</au><au>Ajelli, Marco</au><au>Trentini, Filippo</au><au>Wang, Lili</au><au>Li, Fangcai</au><au>Yang, Juan</au><au>Xiang, Xingyu</au><au>Liao, Qiaohong</au><au>Zhou, Jiaxin</au><au>Guo, Jinxin</au><au>Yan, Xuemei</au><au>Liu, Nuolan</au><au>Metcalf, C. Jessica E.</au><au>Grenfell, Bryan T.</au><au>Yu, Hongjie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term measles antibody profiles following different vaccine schedules in China, a longitudinal study</atitle><jtitle>Nature communications</jtitle><stitle>Nat Commun</stitle><addtitle>Nat Commun</addtitle><date>2023-03-29</date><risdate>2023</risdate><volume>14</volume><issue>1</issue><spage>1746</spage><epage>1746</epage><pages>1746-1746</pages><artnum>1746</artnum><issn>2041-1723</issn><eissn>2041-1723</eissn><abstract>Characterizing the long-term kinetics of maternally derived and vaccine-induced measles immunity is critical for informing measles immunization strategies moving forward. Based on two prospective cohorts of children in China, we estimate that maternally derived immunity against measles persists for 2.4 months. Following two-dose series of measles-containing vaccine (MCV) at 8 and 18 months of age, the immune protection against measles is not lifelong, and antibody concentrations are extrapolated to fall below the protective threshold of 200 mIU/ml at 14.3 years. A catch-up MCV dose in addition to the routine doses between 8 months and 5 years reduce the cumulative incidence of seroreversion by 79.3–88.7% by the age of 6 years. Our findings also support a good immune response after the first MCV vaccination at 8 months. These findings, coupled with the effectiveness of a catch-up dose in addition to the routine doses, could be instrumental to relevant stakeholders when planning routine immunization schedules and supplemental immunization activities. The timing of measles vaccination in infants affects the risk of infection in young children and the duration of protection provided. Here, the authors investigate optimal vaccination timing by characterising antibody kinetics following different vaccine schedules in two cohorts of children in southern China.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>36990986</pmid><doi>10.1038/s41467-023-37407-x</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-1753-4749</orcidid><orcidid>https://orcid.org/0000-0001-5028-2227</orcidid><orcidid>https://orcid.org/0000-0002-6335-5648</orcidid><orcidid>https://orcid.org/0000-0003-3166-7521</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2041-1723
ispartof Nature communications, 2023-03, Vol.14 (1), p.1746-1746, Article 1746
issn 2041-1723
2041-1723
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_0ecd787a51cf4e5babfabd8d7d2f27e3
source Publicly Available Content Database; Nature; PubMed Central; Springer Nature - nature.com Journals - Fully Open Access
subjects 101/1
631/326/590
631/326/596/1631
692/699/255/2514
692/700/478/174
Adolescent
Antibodies
Antibodies, Viral
Child
Children
China - epidemiology
Health risks
Humanities and Social Sciences
Humans
Immune response
Immune system
Immunity
Immunization
Infant
Kinetics
Longitudinal Studies
Measles
Measles - epidemiology
Measles - prevention & control
Measles Vaccine
multidisciplinary
Prospective Studies
Schedules
Science
Science (multidisciplinary)
Vaccination
Vaccines
title Long-term measles antibody profiles following different vaccine schedules in China, a longitudinal study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T10%3A59%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20measles%20antibody%20profiles%20following%20different%20vaccine%20schedules%20in%20China,%20a%20longitudinal%20study&rft.jtitle=Nature%20communications&rft.au=Wang,%20Qianli&rft.date=2023-03-29&rft.volume=14&rft.issue=1&rft.spage=1746&rft.epage=1746&rft.pages=1746-1746&rft.artnum=1746&rft.issn=2041-1723&rft.eissn=2041-1723&rft_id=info:doi/10.1038/s41467-023-37407-x&rft_dat=%3Cproquest_doaj_%3E2792902315%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c541t-7b76f13568a7dc1c9946830b263f50c6465a3f7cd72203df44b50ac86550d9df3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2792195662&rft_id=info:pmid/36990986&rfr_iscdi=true